Drug
AZD8529
AZD8529 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_2
1
17%
Ph early_phase_1
1
17%
Ph phase_1
4
67%
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
1(16.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (16.7%)
Phase 14 (66.7%)
Phase 21 (16.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
The Study of AZD8529 for Smoking Cessation in Female Smokers
NCT02401022
completedphase_1
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531
completedearly_phase_1
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
NCT00985933
completedphase_1
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00886756
completedphase_1
AZD8529 Multiple Ascending Dose Study in Healthy Subjects
NCT00765492
Clinical Trials (6)
Showing 6 of 6 trials
NCT02401022Phase 2
The Study of AZD8529 for Smoking Cessation in Female Smokers
NCT00986531Phase 1
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00985933Early Phase 1
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
NCT00886756Phase 1
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00765492Phase 1
AZD8529 Multiple Ascending Dose Study in Healthy Subjects
NCT00755378Phase 1
AZD8529 Single Ascending Dose Study
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6